• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用健康技术评估支持加拿大循证决策:学术视角。

Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.

机构信息

Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60.

DOI:10.1586/erp.11.60
PMID:21958096
Abstract

Health technology assessment (HTA) adopts a multidisciplinary approach to comprehensively assess safety, efficacy, effectiveness, economic and organizational impact, and any potential social and ethical implications associated with adoption and diffusion of a technology in a healthcare system. Canada was one of the first pioneers in using HTA as a research tool to support evidence-based decision-making. This article describes the current application of HTA in Canada, with a focus on some federal and Ontario initiatives in which the authors have extensive knowledge and experience to illustrate how academic researchers conduct HTA in collaboration with decision makers. Some issues and challenges are also highlighted that will hopefully stimulate a broader discussion among HTA stakeholders to move HTA forward.

摘要

健康技术评估(HTA)采用多学科方法,全面评估安全性、疗效、有效性、经济和组织影响,以及在医疗保健系统中采用和推广技术所涉及的任何潜在的社会和伦理影响。加拿大是最早将 HTA 用作研究工具以支持循证决策的国家之一。本文描述了 HTA 在加拿大的当前应用,重点介绍了作者具有丰富知识和经验的一些联邦和安大略省倡议,以说明学术研究人员如何与决策者合作进行 HTA。本文还强调了一些问题和挑战,希望能激发 HTA 利益相关者更广泛的讨论,推动 HTA 的发展。

相似文献

1
Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.利用健康技术评估支持加拿大循证决策:学术视角。
Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60.
2
Use of health technology assessment in decision making: coresponsibility of users and producers?卫生技术评估在决策中的应用:使用者与生产者的共同责任?
Int J Technol Assess Health Care. 2005 Spring;21(2):268-75.
3
Health technology assessment and primary data collection for reducing uncertainty in decision making.卫生技术评估与原始数据收集以减少决策中的不确定性
J Am Coll Radiol. 2009 May;6(5):332-42. doi: 10.1016/j.jacr.2009.01.012.
4
[The curriculum Health Technology Assessment (HTA)].[卫生技术评估(HTA)课程]
Z Arztl Fortbild Qualitatssich. 2006;100(4):297-302.
5
Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.健康技术评估以优化健康技术的利用:使用实施举措和监测流程。
Int J Technol Assess Health Care. 2010 Jul;26(3):309-16. doi: 10.1017/S0266462310000309.
6
Development and implementation of health technology assessment in Argentina: two steps forward and one step back.阿根廷卫生技术评估的发展与实施:前进两步,后退一步。
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:260-9. doi: 10.1017/S0266462309090734. Epub 2009 Jun 16.
7
Health technology assessment: research trends and future priorities in Europe.卫生技术评估:欧洲的研究趋势和未来重点。
J Health Serv Res Policy. 2011 Jul;16 Suppl 2:6-15. doi: 10.1258/jhsrp.2011.011050.
8
Patient-based health technology assessment: a vision of the future.基于患者的卫生技术评估:未来展望
Int J Technol Assess Health Care. 2007 Winter;23(1):30-5. doi: 10.1017/S0266462307051549.
9
[Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].[卫生技术评估对德国医师与患者常设委员会的影响及相关经验]
Z Arztl Fortbild Qualitatssich. 2002 Feb;96(2):82-90.
10
Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.将卫生技术评估建议纳入组织和临床实践:加泰罗尼亚的一个案例研究。
Int J Technol Assess Health Care. 2006 Spring;22(2):169-76. doi: 10.1017/S0266462306050987.

引用本文的文献

1
Enhancing older care services: a comprehensive internet + community home indicator system.加强老年护理服务:全面的互联网+社区家庭指标系统。
BMC Public Health. 2024 Oct 5;24(1):2713. doi: 10.1186/s12889-024-20221-5.
2
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.多准则决策分析(MCDA)在优先考虑健康技术管理的真实世界证据研究中的应用:加拿大癌症药物价值真实世界证据(CanREValue)合作的结果和经验教训。
Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141.
3
Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals.
中国医院为基础的卫生技术评估介绍:来自七个试点医院的经验。
Int J Technol Assess Health Care. 2024 Jan 29;40(1):e20. doi: 10.1017/S0266462323002738.
4
Reimbursement decision-making system in Poland systematically compared to other countries.波兰的报销决策系统与其他国家进行了系统比较。
Front Pharmacol. 2023 Oct 13;14:1153680. doi: 10.3389/fphar.2023.1153680. eCollection 2023.
5
Emergency contraception subsidy in Canada: a comparative policy analysis.加拿大的紧急避孕补贴:比较政策分析。
BMC Health Serv Res. 2022 Sep 1;22(1):1110. doi: 10.1186/s12913-022-08416-1.
6
Mapping of Health Technology Assessment (HTA) teaching and training initiatives: Landscape for evidence-based policy decisions in India.卫生技术评估(HTA)教学与培训举措的映射:印度基于证据的政策决策格局
J Family Med Prim Care. 2020 Nov 30;9(11):5458-5467. doi: 10.4103/jfmpc.jfmpc_920_20. eCollection 2020 Nov.
7
Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.多准则决策分析在卫生技术评估中的应用:应对方法学挑战,提升现有技术水平。
Eur J Health Econ. 2019 Aug;20(6):891-918. doi: 10.1007/s10198-019-01052-3. Epub 2019 Apr 20.
8
Establishment of a Quantitative Medical Technology Evaluation System and Indicators within Medical Institutions.医疗机构内定量医学技术评估体系和指标的建立。
Chin Med J (Engl). 2018 Jun 5;131(11):1327-1332. doi: 10.4103/0366-6999.232804.
9
Management of Medical Technology under the New Medical Policy Background in China.中国新医改政策背景下的医疗技术管理
Chin Med J (Engl). 2016 Nov 20;129(22):2745-2748. doi: 10.4103/0366-6999.193453.